The "Elevate" by MAPS Podcast

Objectives: 

At the end of this series of podcasts, the participant should be able to:

·         Discuss the functions and activities of key internal partners

·         Identify potential areas for compliant collaboration by MSLs with key internal partners

Moderator: Kathryn Gann, PhD, Independent Consultant
Interviewer: Robert Groebel, VP, Global Medical Strategy, Monocl
Speaker: Ricardo Maamari, MD, NCMP, Global Medical Executive Director, Established/Optimized Portfolio and Rare Diseases, Novartis

The podcast objectives are to : 

·      Discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers.

·      Offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.

Objectives: 

At the end of this series of podcasts, the participant should be able to:

• Discuss the functions and activities of key internal partners
• Identify potential areas for compliant collaboration by MSLs with key internal partners

Moderator: Kathryn Gann, Independent Consultant
Interviewer: Donna Holder, PharmD, Senior Director, Global MSL Excellence, Daiichi Sankyo, Inc,
Speaker: Mary Beth DeYoung PhD, Publications Lead, AstraZeneca

The podcast objectives are to : 

• Discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers
• Offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.

Moderator: Rishi Ohri, MBA, MS, Sr. Director MA Digital Excellence, Astellas Pharma

Interviewee: Jonathan Davies, MSc, Vice President Operational Excellence, Medical Affairs, Astellas Pharma

 At the end of this series of podcasts, the participant should be able to:

·         Discuss the functions and activities of key internal partners

·         Identify potential areas for compliant collaboration by MSLs with key internal partners

The podcast objectives are to : 

·      To discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers.

·      To offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.

Moderator: Rishi Ohri, MBA, MS, Sr. Director MA Digital Excellence, Astellas Pharma
Interviewee: Robert Stevens, Vice President & Global Head, Digital Medical Affairs, Novartis Pharma AG

Objectives: 

At the end of this series of podcasts, the participant should be able to:

·         Discuss the functions and activities of key internal partners

·         Identify potential areas for compliant collaboration by MSLs with key internal partners

Moderator: Kathryn Gann, Independent Consultant
Interviewer: Amanda Logue, Oncology, Global MSL Excellence Director, AstraZeneca
Paul Naish, Director, UK Policy, AstraZeneca

The podcast objectives are to : 

1. explain what publication plain-language summaries are and how patients find them useful 
2. share patient experience of being involved in reviewing PLS, and key points to consider from a patient’s perspective when developing PLS  

Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development, CMC Affinity, a McCann Health Company

Interviewee: Simon R. Stones BSc (Hons) MMRS, Health Advocate and Consultant, Collaboro Consulting

At the end of this series of podcasts, the participant should be able to:

·         Discuss the functions and activities of key internal partners

·         Identify potential areas for compliant collaboration by MSLs with key internal partners

Moderator: Kathryn Gann, Independent Consultant

Interviewer: Ralph Rewers, National MSL Director, Anti-Infectives/HCV/Virology, AbbVie

Guest: Shontelle Dodson, PharmD, Sr. VP of Health Systems, Astellas Pharmaceuticals

In this second of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs.